# Eneura Therapeutics, LLC

- Location (FDA's records): Orono, MN
- FDA decisions: 2 (2013–2014): 1 510(k) clearance and 1 De Novo grant
- Names in FDA's records: Eneura Therapeutics, LLC (1); Eneura Therapeutics (1)
- Product codes: OKP (2)
- Predicates its devices cite: 1 (1 its own); citations of its devices by later devices: 3 (1 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms that cite its devices most
- Eneura, Inc.: 2 (https://510kreport.com/company/eneura)

## Its most-cited devices
- K140094: Springtms Total Migraine System (2014), cited by 2
- DEN130022: Neuralieve Cerena Transcranial Magnetic Stimulator (2013), cited by 1

## Recent decisions
- K140094: Springtms Total Migraine System (May 21, 2014)
- DEN130022: Neuralieve Cerena Transcranial Magnetic Stimulator (Dec 13, 2013)

Source page: https://510kreport.com/company/eneura-therapeutics